WASHINGTON — After two years of haggling, Congress has reached a deal to rein in the drug-industry middlemen known as pharmacy benefit managers.
Lawmakers agreed to extend telehealth flexibilities, fund public health programs, and enact these major PBM changes as part of a government funding package they are planning to pass before the end of the year.
If lawmakers can’t get the necessary votes to pass the overall government spending package, the health deal could still be in jeopardy.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
